JSE firms amid coronavirus vaccine hopes

The JSE pushed higher in broad-based gains on Friday morning, lifted by optimism about a viable Covid-19 vaccine in coming months.

Drugmaker Pfizer may submit its vaccine for regulatory review in October — news that helped to lift sentiment, which has been buffeted by concern about the effect of the pandemic on economic activity.